Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2008
CD40-induced signaling in human endothelial cells results in mTORC2- and Akt-dependent expression of vascular endothelial growth factor in vitro and in vivoOlivier Dormond, Alan G Contreras, Esther Meijer, et al.
Cancer Research|November 12, 2009
Calcineurin inhibitors activate the proto-oncogene Ras and promote protumorigenic signals in renal cancer cellsDipak Datta, Alan G Contreras, Aninda Basu, et al.
Annals of Surgery|June 24, 2005
Prevention of intra-abdominal adhesions using the antiangiogenic COX-2 inhibitor celecoxibArin K Greene, Ian P J Alwayn, Vania Nose, et al.
Carcinogenesis|December 29, 2021
A Combination therapy using an mTOR inhibitor and Honokiol effectively induces autophagy through the modulation of AXL and Rubicon in renal cancer cells and restricts renal tumor growth following organ transplantationAkash Sabarwal, Johannes Wedel, Kaifeng Liu, et al.
The American Journal of Pathology|January 27, 2006
Vascular endothelial growth factor antagonist modulates leukocyte trafficking and protects mouse livers against ischemia/reperfusion injurySei-ichiro Tsuchihashi, Bibo Ke, Fady Kaldas, et al.
Cancer Research|July 18, 2008
Overexpression of vascular endothelial growth factor and the development of post-transplantation cancerAninda Basu, Alan G Contreras, Dipak Datta, et al.
Cancer Cell|June 5, 2003
A peptide trivalent arsenical inhibits tumor angiogenesis by perturbing mitochondrial function in angiogenic endothelial cellsAnthony S Don, Oliver Kisker, Pierre Dilda, et al.
The Journal of Surgical Research|April 1, 2008
Inhibition of intra-abdominal adhesion formation with the angiogenesis inhibitor sunitinibSendia Kim, Sang Lee, Arin K Greene, et al.
Cancer Letters|February 21, 2012
Effectiveness of a combination therapy using calcineurin inhibitor and mTOR inhibitor in preventing allograft rejection and post-transplantation renal cancer progressionAninda Basu, Tao Liu, Pallavi Banerjee, et al.
Neoplasia (New York, N.Y.)|March 28, 2003
Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in miceOliver Kisker, Shinya Onizuka, Christian M Becker, et al.
Pageof 3